Down-regulation of TRAF6 results in enhanced constitutive AKT activation through phosphorylating residues Thr308 and Ser473 in MV4-11 cells (FLT3-ITD AML cells). The gene discussed is TRAF6; the disease is acute myeloid leukemia.